TRIDENT LIFELINE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 190 INR | +4.97% |
|
+7.80% | +1.06% |
| 05-17 | Trident Lifeline's CFO Resigns | MT |
| 05-16 | Trident Lifeline Limited Announces Resignation of Mayurkumar Mansukhbhai Gajera as Chief Financial Officer | CI |
| Sales 2022 | 218M 2.61M 3.57M | Sales 2023 | 317M 3.79M 5.2M | Capitalization | 1.83B 21.9M 30M |
|---|---|---|---|---|---|
| Net income 2022 | 22M 263K 361K | Net income 2023 | 60M 718K 984K | EV / Sales 2022 * | - |
| Net Debt 2022 | 23.24M 278K 381K | Net cash position 2023 | 81.46M 975K 1.34M | EV / Sales 2023 | 5.52 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
25.5
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.53% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.97% | ||
| 1 week | +7.80% | ||
| Current month | +26.25% | ||
| 1 month | +2.70% | ||
| 3 months | +26.67% | ||
| 6 months | +7.92% | ||
| Current year | +1.06% |
1 week
172.50
201.00
1 month
144.10201.00
Current year
136.00212.80
1 year
128.25239.70
3 years
102.75239.70
5 years
102.75239.70
10 years
102.75239.70
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 30 | 22-06-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 15-02-25 | |
Maniya Desai
BRD | Director/Board Member | 39 | 22-06-26 |
| Chief Executive Officer | 30 | 22-06-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-21 | 190 | +4.97% | 15,600 |
| 24-06-20 | 181 | +0.56% | 15,000 |
| 24-06-19 | 180 | -2.65% | 1,800 |
| 24-06-18 | 184.9 | +4.91% | 2,400 |
| 24-06-14 | 176.2 | -4.21% | 4,800 |
Delayed Quote Bombay S.E., June 21, 2024 at 06:00 am
More quotes
Trident Lifeline Limited is an India-based pharmaceutical company, which is engaged in providing of capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. The Company operates through seven geographical segments: India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, Rest of World. The Company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, Non-Steroidal Anti-Inflammatory Drug (NSAIDS).
Sector
Pharmaceuticals
Calendar
2024-07-14
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +1.06% | 26.14M | |
| +51.63% | 796B | |
| +41.51% | 628B | |
| -5.10% | 358B | |
| +19.90% | 331B | |
| +9.95% | 301B | |
| +17.66% | 244B | |
| +3.39% | 228B | |
| +10.75% | 214B | |
| +6.99% | 165B |
- Stock Market
- Equities
- 543616 Stock
